Claritas Pharmaceuticals Company Description

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021.

Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.

Claritas Pharmaceuticals, Inc.

Country	Canada
Founded	2014
Industry	Biotechnology
Sector	Healthcare
CEO	Robert Farrell

Contact Details

Address:

4040 Civic Center Drive
San Rafael, British Columbia 94903
United States

Stock Details

Ticker Symbol	CLAZF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CA1806342061
SIC Code	2834

Key Executives

Name	Position
Robert Farrell J.D.	Chairman, Chief Executive Officer and President
Victoria Diana Rudman	Interim Chief Financial Officer, Treasurer and Secretary
Seth Yakatan	Co-Founder
Dr. Stuart L. Silverman FACP, FACR, M.D.	Chair of Scientific Advisory Board and Vice President of Medical Affairs
Dr. Sari Prutchi-Sagiv Ph.D.	Chief Scientific Officer
Dr. Moshe Yeshurun M.D.	Chief Medical Officer
Dr. Amos Rosenthal Ph.D.	Head of Chemistry